References
- Jha, P., C. Ramasundarahettige, V. Landsman, B. Rostron, M. Thun, R.N. Anderson, T. McAfee, and R. Peto: 21st-Century Hazards of Smoking and Benefits of Cessation in the United States; N. Engl. J. Med. 368 (2013) 341–350. DOI: 10.1056/NEJMsa1211128
- Mons, U.: Tabakattributable Mortalität in Deutschland und in den Deutschen Bundesländern – Berechnungen mit Daten des Mikrozensus und der Todesursachenstatistik [Tobacco-Attributable Mortality in Germany and in the German Federal States - Calculations With Data From a Microcensus and Mortality Statistics]; Gesundheitswesen 73 (2011) 238–246. DOI: 10.1055/s-0030-1252039
- World Health Organization (WHO): WHO Global Report on Trends in Prevalence of Tobacco Smoking 2015; World Health Organization, Geneva, 2015. Available from: https://www.who.int/tobacco/publications/surveillance/reportontrendstobaccosmoking/en/index4.html (accessed March 2022)
- Kotz, D., M. Bockmann, and S. Kastaun: The Use of Tobacco, E-Cigarettes, and Methods to Quit Smoking in Germany: A Representative Study Using 6 Waves of Data Over 12 Months (the DEBRA Study); Dtsch. Arztebl. Int. 115 (2018) 235–242. DOI: 10.3238/arztebl.2018.0235
- Kotz, D., A. Batra, and S. Kastaun: Smoking Cessation Attempts and Common Strategies Employed: A Germany-Wide Representation Survey Conducted in 19 Waves From 2016 to 2019 (the DEBRA Study) and Analyzed by Socioeconomic Status; Dtsch. Ärztebl. Int. 117 (2020) 7–13. DOI: 10.3238/ärztebl.2020.0007
- Mons, U. and H. Brenner: Demographic Ageing and the Evolution of Smoking-Attributable Mortality: The Example of Germany; Tob. Control 26 (2017) 455–457. DOI: 10.1136/tobaccocontrol-2016-053008
- Chaloupka, F.J., D. Sweanor, and K.E. Warner: Differential Taxes for Differential Risks – Toward Reduced Harm From Nicotine-Yielding Products; N. Engl. J. Med. 373 (2015) 594–597. DOI: 10.1056/NEJMp1505710
- Royal College of Physicians (RCP): Nicotine Without Smoke: Tobacco Harm Reduction; RCP, London, UK, 2016. Available from: www.rcplondon.ac.uk/projects/outputs/nicotine-without-smoke-tobacco-harm-reduction (accessed March 2022)
- Kozlowski, L.T. and D.B. Abrams: Obsolete Tobacco Control Themes can be Hazardous to Public Health: The Need for Updating Views on Absolute Product Risks and Harm Reduction; BMC Public Health 16 (2016) 432. DOI: 10.1186/s12889-016-3079-9
- Abrams, D.B., A.M. Glasser, A.C. Villanti, J.L. Pearson, S. Rose, and R.S. Niaura: Managing Nicotine Without Smoke to Save Lives Now: Evidence for Harm Minimization; Prev. Med. 117 (2018) 88–97. DOI: 10.1016/j.ypmed.2018.06.010
- Abrams, D.B., A.M. Glasser, J.L. Pearson, A.C. Villanti, L.K. Collins, and R.S. Niaura: Harm Minimization and Tobacco Control: Reframing Societal Views of Nicotine Use to Rapidly Save Lives; Annu. Rev. Public Health 39 (2018) 193–213. DOI: 10.1146/annurev-publhealth-040617-013849
- Fairchild, A., C. Healton, J. Curran, D. Abrams, and R. Bayer: Evidence, Alarm, and the Debate Over E-Cigarettes; Science 366 (2019) 1318–1320. DOI: 10.1126/science.aba0032
- McNeill, A., L.S. Brose, R. Calder, L. Bauld, and D. Robson: Evidence Review of E-Cigarettes and Heated Tobacco Products. A Report Commissioned by Public Health England; Public Health England, London, UK, 2018. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/684963/Evidence_review_of_e-cigarettes_and_heated_tobacco_products_2018.pdf (accessed March 2022)
- Schaller, J.P., D. Keller, L. Poget, P. Pratte, E. Kaelin, D. McHugh, G. Cudazzo, D. Smart, A.R. Tricker, L. Gautier, M. Yerly, R. Reis Pires, S. Le Bouhellec, D. Ghosh, I. Hofer, E. Garcia, P. Vanscheeuwijck, and S. Maeder: Evaluation of the Tobacco Heating System 2.2. Part 2: Chemical Composition, Genotoxicity, Cytotoxicity, and Physical Properties of the Aerosol; Regul. Toxicol. Pharmacol. 81 (2016) S27–S47. DOI: 10.1016/j.yrtph.2016.10.001
- Mallock, N., L. Böss, R. Burk, M. Danziger, T. Welsch, H. Hahn, H.L. Trieu, J. Hahn, E. Pieper, F. Henkler-Stephani, C. Hutzler, and A. Luch: Levels of Selected Analytes in the Emissions of “Heat not Burn” Tobacco Products That are Relevant to Assess Human Health Risks; Arch. Toxicol. 92 (2018) 2145–2149. DOI: 10.1007/s00204-018-2215-y
- Ramström, L. and T. Wikmans: Mortality Attributable to Tobacco Among Men in Sweden and Other European Countries: An Analysis of Data in a WHO Report; Tob. Induc. Dis. 12 (2014) 14. DOI: 10.1186/1617-9625-12-14
- Hajek, P., A. Phillips-Waller, D. Przulj, F. Pesola, K. Myers Smith, N. Bisal, J. Li, S. Parrott, P. Sasieni, L. Dawkins, L. Ross, M. Goniewicz, Q. Wu, and H.J. McRobbie: A Randomized Trial of E-Cigarettes Versus Nicotine-Replacement Therapy; N. Engl. J. Med. 380 (2019) 629–637. DOI: 10.1056/NEJMoa1808779
- Beard, E., R. West, S. Michie, and J. Brown: Association of Prevalence of Electronic Cigarette Use With Smoking Cessation and Cigarette Consumption in England: A Time-Series Analysis Between 2006 and 2017; Addiction 115 (2019) 961–974. DOI: 10.1111/add.14851
- Bauld, L., A.M. MacKintosh, B. Eastwood, A. Ford, G. Moore, M. Dockrell, D. Arnott, H. Cheeseman, and A. McNeill: Young People's Use of E-Cigarettes Across the United Kingdom: Findings From Five Surveys 2015–2017; Int. J. Environ. Res. Public Health 14 (2017). DOI: 10.3390/ijerph14090973
- Walker, N., V. Parag, S.F. Wong, B. Youdan, B. Broughton, C. Bullen, and R. Beaglehole: Use of E-Cigarettes and Smoked Tobacco in Youth Aged 14–15 Years in New Zealand: Findings From Repeated Cross-Sectional Studies (2014–19); Lancet Public Health 5 (2020) e204–e212. DOI: 10.1016/s2468-2667(19)30241-5
- Levy, D.T., K.E. Warner, K.M. Cummings, D. Hammond, C. Kuo, G.T. Fong, J.F. Thrasher, M.L. Goniewicz, and R. Borland: Examining the Relationship of Vaping to Smoking Initiation Among US Youth and Young Adults: A Reality Check; Tob. Control 28 (2019) 629–635. DOI: 10.1136/tobaccocontrol-2018-054446
- Sokol, N.A. and J.M. Feldman: High School Seniors who Used E-Cigarettes may Have Otherwise Been Cigarette Smokers: Evidence From Monitoring the Future (United States, 2009–2018); Nicotine Tob. Res. 23 (2021) 1958–1961. DOI: 10.1093/ntr/ntab102
- Stoklosa, M., Z. Cahn, A. Liber, N. Nargis, and J. Drope: Effect of IQOS Introduction on Cigarette Sales: Evidence of Decline and Replacement; Tob. Control 29 (2019) 381–387. DOI: 10.1136/tobaccocontrol-2019-054998
- Orth, B. and C. Merkel: Die Drogenaffinität Jugendlicher in der Bundesrepublik Deutschland 2019. Rauchen, Alkoholkonsum und Konsum illegaler Drogen: Aktuelle Verbreitung und Trends; Bundeszentrale für gesundheitliche Aufklärung (BZGA), Cologne, Germany 2020. DOI: 10.17623/BZGA:225-DAS19-DE-1.0
- Kotz, D. and S. Kastaun: Invited Lecture: Consumption of Cigarettes, Waterpipe, E-Cigarettes and Heated Tobacco Products in Germany: Current Data From the DEBRA Study; Deutsche Befragung zum Rauchverhalten (DEBRA), 18th German Tobacco Control Conference, Heidelberg, Online, 02 December 2020. Available from: https://www.debra-study.info/forschung (accessed March 2022)
- Orth, B. and C. Merkel: Rauchen bei Jugendlichen und jungen Erwachsenen in Deutschland 2018: Ergebnisse des Alkoholsurveys 2018 und Trends; Bundeszentrale für gesundheitliche Aufklärung (BZGA), Cologne, Germany, 2019. DOI: 10.17623/BZGA:225-ALKSY18-RAU-DE-1.0
- Lee, P.N., J.S. Fry, J.F. Hamling, Z. Sponsiello-Wang, G. Baker, and R. Weitkunat: Estimating the Effect of Differing Assumptions on the Population Health Impact of Introducing a Reduced Risk Tobacco Product in the USA; Regul. Toxicol. Pharmacol. 88 (2017) 192–213. DOI: 10.1016/j.yrtph.2017.06.009
- Djurdjevic, S., P.N. Lee, R. Weitkunat, Z. Sponsiello-Wang, F. Lüdicke, and G. Baker: Modeling the Population Health Impact of Introducing a Modified Risk Tobacco Product Into the U.S. Market; Healthcare (Basel) 6 (2018) 47. DOI: 10.3390/healthcare6020047
- Lee, P.N., S. Djurdjevic, R. Weitkunat, and G. Baker: Estimating the Population Health Impact of Introducing a Reduced-Risk Tobacco Product Into Japan. The Effect of Differing Assumptions, and Some Comparisons With the U.S.; Regul. Toxicol. Pharmacol. 100 (2018) 92–104. DOI: 10.1016/j.yrtph.2018.10.010
- Weitkunat, R., P.N. Lee, G. Baker, Z. Sponsiello-Wang, A.M. González-Zuloeta Ladd, and F. Lüdicke: A Novel Approach to Assess the Population Health Impact of Introducing a Modified Risk Tobacco Product; Regul. Toxicol. Pharmacol. 72 (2015) 87–93. DOI: 10.1016/j.yrtph.2015.03.011
- Fry, J.S., P.N. Lee, B.A. Forey, and K.J. Coombs: How Rapidly Does the Excess Risk of Lung Cancer Decline Following Quitting Smoking? A Quantitative Review Using the Negative Exponential Model; Regul. Toxicol. Pharmacol. 67 (2013) 13–26. DOI: 10.1016/j.yrtph.2013.06.001
- Lee, P.N., J.S. Fry, and B.A. Forey: Estimating the Decline in Excess Risk of Chronic Obstructive Pulmonary Disease Following Quitting Smoking – A Systematic Review Based on the Negative Exponential Model; Regul. Toxicol. Pharmacol. 68 (2014) 231–239. DOI: 10.1016/j.yrtph.2013.12.006
- Lee, P.N., J.S. Fry, and J.S. Hamling: Using the Negative Exponential Distribution to Quantitatively Review the Evidence on how Rapidly the Excess Risk of Ischaemic Heart Disease Declines Following Quitting Smoking; Regul. Toxicol. Pharmacol. 64 (2012) 51–67. DOI: 10.1016/j.yrtph.2012.06.009
- Lee, P.N., J.S. Fry, and A. Thornton: Estimating the Decline in Excess Risk of Cerebrovascular Disease Following Quitting Smoking - A Systematic Review Based on the Negative Exponential Model; Regul. Toxicol. Pharmacol. 68 (2014) 85–95. DOI: 10.1016/j.yrtph.2013.11.013
- Gardner, J.W. and J.S. Sanborn: Years of Potential Life Lost (YPLL) – What Does it Measure?; Epidemiology 1 (1990) 322–329. DOI: 10.1097/00001648-199007000-00012
- United Nations Department of Economic and Social Affairs Population Division: World Population Prospects: The 2015 Revision; United Nations, New York, NY, USA. Available at: http://esa.un.org/unpd/wpp/Download/Standard/Population/
- Forey, B., J. Hamling, J. Hamling, A. Thornton and P. Lee: International Smoking Statistics. A Collection of Worldwide Historical Data (2006–2016); Available at: www.pnlee.co.uk/iss.htm (accessed March 2022)
- Forey, B.A. and P.N. Lee: A Comparison of Smoking Prevalence and Quitting Between Countries Which use Either Virginia or Blended Tobacco Cigarettes; PN Lee Statistics and Computing Ltd, Sutton, Surrey, UK, 2012. Available from: www.pnlee.co.uk/Reports.htm [Download FOREY2012]
- Bennewitz, E. and A. Kaul: Quitting Smoking in Germany: Evidence From the SOEP; Saarland University, Saarbrücken, Germany, 2020. Available at: https://www.uni-saarland.de/fileadmin/user_upload/Professoren/fr12_ProfKaul/Research/2020_01_29_Quitting_Smoking.pdf (accessed March 2022)
- Martin, F., G. Vuillaume, G. Baker, Z. Sponsiello-Wang, P.F. Ricci, F. Lüdicke, and R. Weitkunat: Quantifying the Risk-Reduction Potential of New Modified Risk Tobacco Products; Regul. Toxicol. Pharmacol. 92 (2018) 358–369. DOI: 10.1016/j.yrtph.2017.12.011
- Nutt, D.J., L.D. Phillips, D. Balfour, H.V. Curran, M. Dockrell, J. Foulds, K. Fagerstrom, K. Letlape, A. Milton, R. Polosa, J. Ramsey, and D. Sweanor: Estimating the Harms of Nicotine-Containing Products Using the MCDA Approach; Eur. Addict. Res. 20 (2014) 218–225. DOI: 10.1159/000360220
- World Health Organization (WHO): WHO Mortality Database; available at: http://www.who.int/healthinfo/mortality_data/en/ (accessed March 2022)
- Levy, D.T., R. Borland, E.N. Lindblom, M.L. Goniewicz, R. Meza, T.R. Holford, Z. Yuan, Y. Luo, R.J. O’Connor, R. Niaura, and D.B. Abrams: Potential Deaths Averted in USA by Replacing Cigarettes With E-Cigarettes; Tob. Control 27 (2018) 18–25. DOI: 10.1136/tobaccocontrol-2017-053759
- Zhu, S.H., Y.L. Zhuang, S. Wong, S.E. Cummins, and G.J. Tedeschi: E-Cigarette use and Associated Changes in Population Smoking Cessation: Evidence From US Current Population Surveys; BMJ 358 (2017) j3262. DOI: 10.1136/bmj.j3262
- Lee, P.N., J. Hamling, J. Fry, and B. Forey: Using the Negative Exponential Model to Describe Changes in Risk of Smoking-Related Diseases Following Changes in Exposure to Tobacco; Advances in Epidemiology, Article ID 487876 (2015) 13 pages. DOI: 10.1155/2015/487876
- Brose, L.S., J. Brown, S.C. Hitchman, and A. McNeill: Perceived Relative Harm of Electronic Cigarettes Over Time and Impact on Subsequent Use. A Survey With 1-Year and 2-Year Follow-Ups; Drug Alcohol Depend. 157 (2015) 106–111. DOI: 10.1016/j.drugalcdep.2015.10.014
- Action on Smoking and Health (ASH): Use of E-Cigarettes (Vapes) Among Adults in Great Britain, 2021; ASH, London, UK, 2021. Available at: https://ash.org.uk/wp-content/uploads/2021/06/Use-of-e-cigarettes-vapes-among-adults-in-Great-Britain-2021.pdf (accessed April 2022)
- Atzendorf, J., A.B. Aschenbrenner, E. Gomes de Matos, L. Kraus, C. Kröger, S. Delle, and D. Piontek: E-Zigaretten: Einschätzung von Gesundheitsgefahren und Nutzung zur Tabakentwöhnung (E-Cigarettes: Perceived Harmfulness and Use for Smoking Cessation); Bundesgesundheitsbl. 61 (2018) 1415–1421. DOI: 10.1007/s00103-018-2822-z
- Persoskie, A., E.K. O’Brien, and K. Poonai: Perceived Relative Harm of Using E-Cigarettes Predicts Future Product Switching Among US Adult Cigarette and E-Cigarette Dual Users; Addiction 114 (2019) 2197–2205. DOI: 10.1111/add.14730
- Eichler, M., M. Blettner, and S. Singer: The Use of E-Cigarettes - A Population-Based Cross-Sectional Survey of 4002 Individuals in 2016; Dtsch. Ärztebl. Int. 113 (2016) 847–854. DOI: 10.3238/arztebl.2016.0847
- Verband des eZigarettenhandels (VdeH): E-Zigaretten - die unterschätzte Chance. Was die Deutschen über E-Zigaretten wissen - und was nicht. Ergebnisse der repräsentativen Forsa-Befragung; VdeH, Berlin, Germany, November 2019. Available at: https://vd-eh.de/wp-content/uploads/2019/11/vdeh-forsa-2019.pdf (accessed March 2022)
- Kotz, D. and S. Kastaun: E-Zigaretten und Tabakerhitzer: repräsentative Daten zu Konsumverhalten und assoziierten Faktoren in der deutschen Bevölkerung (die DEBRA-Studie) (E-Cigarettes and Heat-Not-Burn Products: Representative Data on Consumer Behaviour and Associated Factors in the German Population (The DEBRA Study)); Bundesgesundheitsbl. 61 (2018) 1407–1414. DOI: 10.1007/s00103-018-2827-7
- Kozlowski, L.T. and D. Sweanor: Withholding Differential Risk Information on Legal Consumer Nicotine/Tobacco Products: The Public Health Ethics of Health Information Quarantines; Int. J. Drug Policy 32 (2016) 17–23. DOI: 10.1016/j.drugpo.2016.03.014
- Science Media Center Germany (SMC): Press Briefing: Wie sollen E-Zigaretten künftig reguliert werden?; SMC gGmbH, Heidelberg, Germany, 21 January 2020; Available at: https://www.sciencemediacenter.de/alle-angebote/press-briefing/details/news/wie-sollen-e-zigaretten-kuenftig-reguliert-werden/ (accessed March 2022)
- Weaver, S.R., A. Jazwa, L. Popova, P. Slovic, R.B. Rothenberg, and M.P. Eriksen: Worldviews and Trust of Sources for Health Information on Electronic Nicotine Delivery Systems: Effects on Risk Perceptions and Use; SSM Popul. Health 3 (2017) 787–794. DOI: 10.1016/j.ssmph.2017.09.003
- Levy, D.T., G.T. Fong, K.M. Cummings, R. Borland, D.B. Abrams, A.C. Villanti, and R. Niaura: The Need for a Comprehensive Framework; Addiction 112 (2017) 22–24. DOI: 10.1111/add.13600
- Kimber, C., D. Frings, S. Cox, I.P. Albery, and L. Dawkins: Communicating the Relative Health Risks of E-Cigarettes: An Online Experimental Study Exploring the Effects of a Comparative Health Message Versus the EU Nicotine Addiction Warnings on Smokers’ and Non-Smokers’ Risk Perceptions and Behavioural Intentions; Addict. Behav. 101 (2020) 106177. DOI: 10.1016/j.addbeh.2019.106177
- Hummel, K., G.E. Nagelhout, G.T. Fong, C.I. Vardavas, S. Papadakis, A. Herbeć, U. Mons, B. van den Putte, R. Borland, E. Fernández, H. de Vries, A. McNeill, S. Gravely, K. Przewoźniak, P. Kovacs, A.C. Trofor, and M.C. Willemsen: Quitting Activity and use of Cessation Assistance Reported by Smokers in Eight European Countries: Findings From the EUREST-PLUS ITC Europe Surveys; Tob. Induc. Dis. 16 (2018). DOI: 10.18332/tid/98912
- Reimer, J., S. Kuhn, and K. Lehmann: Konsumgewohnheiten und Motive von E-Zigaretten-Konsumenten in Deutschland - Eine Querschnittsanalyse; Zentrum für Interdisziplinäre Suchtforschung der Universität Hamburg (ZIS), Hamburg, Germany, 2016. Available at: https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/5_Publikationen/Drogen_und_Sucht/Berichte/161005_Anlage_5-Abschlussbericht_ZIS.pdf (accessed March 2022)
- Cotti, C.D., C.J. Courtemanche, J.C. Maclean, E.T. Nesson, M.F. Pesko, and N. Tefft: The Effects of E-Cigarette Taxes on E-Cigarette Prices and Tobacco Product Sales: Evidence From Retail Panel Data; National Bureau of Economic Research (NBER), Working Paper 26724, Cambridge, MA, USA, 2020. Available at: https://www.nber.org/papers/w26724.pdf (accessed March 2022)
- Bachand, A.M. and S.I. Sulsky: A Dynamic Population Model for Estimating All-Cause Mortality due to Lifetime Exposure History; Regul. Toxicol. Pharmacol. 67 (2013) 246–251. DOI: 10.1016/j.yrtph.2013.08.003
- Bachand, A.M., S.I. Sulsky, and G.M. Curtin: Assessing the Likelihood and Magnitude of a Population Health Benefit Following the Market Introduction of a Modified-Risk Tobacco Product: Enhancements to the Dynamic Population Modeler, DPM(+1); Risk Anal. 38 (2018) 151–162. DOI: 10.1111/risa.12819
- Black, R., J. Murillo, and Y. Pithawalla (Editors): Population Modeling. A Practical Approach to Evaluate the Net Benefit of a new Tobacco Product; Proceedings of Tobacco Computational Modeling Meeting, NYU College of Global Public Health, July 23–24, 2018.
- Camacho, O.M., A. Hill, S. Fiebelkorn, A. Williams, and J.J. Murphy: Investigating the Health Effects of 3 Coexisting Tobacco and Nicotine Products Using System Dynamics Population Modeling: An Italian Population Case Study; medRxiv Preprint: Apr 19, 2021. DOI: 10.1101/2021.04.12.21255338 Available at: https://www.medrxiv.org/content/10.1101/2021.04.12.21255338v1.full.pdf (accessed March 2022)
- Hill, A. and O.M. Camacho: A System Dynamics Modelling Approach to Assess the Impact of Launching a New Nicotine Product on Population Health Outcomes; Regul. Toxicol. Pharmacol. 86 (2017) 265–278. DOI: 10.1016/j.yrtph.2017.03.012
- Muhammad-Kah, R.S., Y.B. Pithawalla, E.L. Boone, L. Wei, M.A. Jones, R.A. Black, T.M. Bryan, and M.A. Sarkar: A Computational Model for Assessing the Population Health Impact of Introducing a Modified Risk Claim on an Existing Smokeless Tobacco Product; Int. J. Environ. Res. Public Health 16 (2019) 1264. DOI: 10.3390/ijerph16071264
- Poland, B. and F. Teischinger: Population Modeling of Modified Risk Tobacco Products Accounting for Smoking Reduction and Gradual Transitions of Relative Risk; Nicotine Tob. Res. 19 (2017) 1277–1283. DOI: 10.1093/ntr/ntx070
- Apelberg, B.J., S.P. Feirman, E. Salazar, C.G. Corey, B.K. Ambrose, A. Paredes, E. Richman, S.J. Verzi, E.D. Vugrin, N.S. Brodsky, and B.L. Rostron: Potential Public Health Effects of Reducing Nicotine Levels in Cigarettes in the United States; N. Engl. J. Med. 378 (2018) 1725–1733. DOI: 10.1056/NEJMsr1714617
- Kalkhoran, S. and S.A. Glantz: Modeling the Health Effects of Expanding E-Cigarette Sales in the United States and United Kingdom: A Monte Carlo Analysis; JAMA Intern. Med. 175 (2015) 1671–1680. DOI: 10.1001/jamainternmed.2015.4209
- Levy, D.T., R. Borland, A.C. Villanti, R. Niaura, Z. Yuan, Y. Zhang, R. Meza, T.R. Holford, G.T. Fong, K.M. Cummings, and D.B. Abrams: The Application of a Decision-Theoretic Model to Estimate the Public Health Impact of Vaporized Nicotine Product Initiation in the United States; Nicotine Tob. Res. 19 (2017) 149–159. DOI: 10.1093/ntr/ntw158
- Soneji, S.S., H.Y. Sung, B.A. Primack, J.P. Pierce, and J.D. Sargent: Quantifying Population-Level Health Benefits and Harms of E-Cigarette use in the United States; PLoS One 13 (2018) e0193328. DOI: 10.1371/journal.pone.0193328
- Vugrin, E.D., B.L. Rostron, S.J. Verzi, N.S. Brodsky, T.J. Brown, C.J. Choiniere, B.N. Coleman, A. Paredes, and B.J. Apelberg: Modeling the Potential Effects of new Tobacco Products and Policies: A Dynamic Population Model for Multiple Product Use and Harm; PLoS One 10 (2015) e0121008. DOI: 10.1371/journal.pone.0121008
- Warner, K.E. and D. Mendez: E-Cigarettes: Comparing the Possible Risks of Increasing Smoking Initiation With the Potential Benefits of Increasing Smoking Cessation; Nicotine Tob. Res. 21 (2019) 41–47. DOI: 10.1093/ntr/nty062